These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 16772748

  • 1. Amyloid-beta immunotherapies in mice and men.
    Brendza RP, Holtzman DM.
    Alzheimer Dis Assoc Disord; 2006; 20(2):118-23. PubMed ID: 16772748
    [Abstract] [Full Text] [Related]

  • 2. Novel approaches for immunotherapeutic intervention in Alzheimer's disease.
    Vasilevko V, Cribbs DH.
    Neurochem Int; 2006 Jul; 49(2):113-26. PubMed ID: 16765487
    [Abstract] [Full Text] [Related]

  • 3. Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies.
    Geylis V, Steinitz M.
    Autoimmun Rev; 2006 Jan; 5(1):33-9. PubMed ID: 16338209
    [Abstract] [Full Text] [Related]

  • 4. Immunotherapy for Alzheimer's disease.
    McGeer PL, McGeer E.
    Sci Aging Knowledge Environ; 2004 Jul 07; 2004(27):pe29. PubMed ID: 15243154
    [Abstract] [Full Text] [Related]

  • 5. Intracerebroventricular passive immunization with anti-Abeta antibody in Tg2576.
    Chauhan NB, Siegel GJ.
    J Neurosci Res; 2003 Oct 01; 74(1):142-7. PubMed ID: 13130516
    [Abstract] [Full Text] [Related]

  • 6. Evidence supporting a role for anti-Abeta antibodies in the treatment of Alzheimer's disease.
    Morgan D, Gitter BD.
    Neurobiol Aging; 2004 Oct 01; 25(5):605-8. PubMed ID: 15172737
    [Abstract] [Full Text] [Related]

  • 7. Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model.
    Dodart JC, Bales KR, Gannon KS, Greene SJ, DeMattos RB, Mathis C, DeLong CA, Wu S, Wu X, Holtzman DM, Paul SM.
    Nat Neurosci; 2002 May 01; 5(5):452-7. PubMed ID: 11941374
    [Abstract] [Full Text] [Related]

  • 8. Immunization in Alzheimer's disease: naïve hope or realistic clinical potential?
    Foster JK, Verdile G, Bates KA, Martins RN.
    Mol Psychiatry; 2009 Mar 01; 14(3):239-51. PubMed ID: 18957942
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Site-specific UBITh amyloid-beta vaccine for immunotherapy of Alzheimer's disease.
    Wang CY, Finstad CL, Walfield AM, Sia C, Sokoll KK, Chang TY, Fang XD, Hung CH, Hutter-Paier B, Windisch M.
    Vaccine; 2007 Apr 20; 25(16):3041-52. PubMed ID: 17287052
    [Abstract] [Full Text] [Related]

  • 13. Antibody-mediated immunotherapy for Alzheimer's disease.
    Solomon B.
    Curr Opin Investig Drugs; 2007 Jul 20; 8(7):519-24. PubMed ID: 17659471
    [Abstract] [Full Text] [Related]

  • 14. Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning.
    Schenk D.
    Nat Rev Neurosci; 2002 Oct 20; 3(10):824-8. PubMed ID: 12360327
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Genomic analysis of response to traumatic brain injury in a mouse model of Alzheimer's disease (APPsw).
    Crawford FC, Wood M, Ferguson S, Mathura VS, Faza B, Wilson S, Fan T, O'Steen B, Ait-Ghezala G, Hayes R, Mullan MJ.
    Brain Res; 2007 Dec 14; 1185():45-58. PubMed ID: 17961517
    [Abstract] [Full Text] [Related]

  • 17. Vaccination of Alzheimer's model mice with adenovirus vector containing quadrivalent foldable Abeta(1-15) reduces Abeta burden and behavioral impairment without Abeta-specific T cell response.
    Zou J, Yao Z, Zhang G, Wang H, Xu J, Yew DT, Forster EL.
    J Neurol Sci; 2008 Sep 15; 272(1-2):87-98. PubMed ID: 18571202
    [Abstract] [Full Text] [Related]

  • 18. Modulation of microglial activation state following passive immunization in amyloid depositing transgenic mice.
    Morgan D.
    Neurochem Int; 2006 Jul 15; 49(2):190-4. PubMed ID: 16740342
    [Abstract] [Full Text] [Related]

  • 19. Immunotherapy for Alzheimer's disease.
    Solomon B, Frenkel D.
    Neuropharmacology; 2010 Jul 15; 59(4-5):303-9. PubMed ID: 20388523
    [Abstract] [Full Text] [Related]

  • 20. Immunotherapy as treatment for Alzheimer's disease.
    Hawkes CA, McLaurin J.
    Expert Rev Neurother; 2007 Nov 15; 7(11):1535-48. PubMed ID: 17997702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.